Zhang, Y., & Xu, H. (2020). Serum exosomal miR‐378 upregulation is associated with poor prognosis in non–small‐cell lung cancer patients. J Clin Lab Anal.
استشهاد بنمط شيكاغوZhang, Yan, و Hongjie Xu. "Serum Exosomal MiR‐378 Upregulation Is Associated With Poor Prognosis in Non–small‐cell Lung Cancer Patients." J Clin Lab Anal 2020.
MLA استشهادZhang, Yan, و Hongjie Xu. "Serum Exosomal MiR‐378 Upregulation Is Associated With Poor Prognosis in Non–small‐cell Lung Cancer Patients." J Clin Lab Anal 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.